Abstract
Cdc42 was originally discovered as a key regulator of bud site assembly and polarity in S. cerevisiae. Recent genetic studies have shown that the function of Cdc42 in regulating cell polarity appears highly conserved from budding yeast to humans. The role of Cdc42 in hematopoietic cell transformation and leukemia progression has been studied in an acute myeloid leukemia model using the MLL-AF9 oncogene-induced transformation and a Cdc42 conditional gene-targeted mouse model. Here we describe the leukemia cell polarity and division symmetry assays in the context of leukemia cell fate determination.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Clarke MF, Fuller M (2006) Stem cells and cancer: two faces of eve. Cell 124:1111–1115
Dick JE (2008) Stem cell concepts renew cancer research. Blood 112:4793–4807
Hawkins ED, Russell SM (2008) Upsides and downsides to polarity and asymmetric cell division in leukemia. Oncogene 27:7003–7017
Pham K, Sacirbegovic F, Russell SM (2014) Polarized cells, polarized views: asymmetric cell division in hematopoietic cells. Front Immunol 5:26
Yang L, Wang L, Geiger H, Cancelas JA, Mo J, Zheng Y (2007) Rho GTPase Cdc42 coordinates hematopoietic stem cell quiescence and niche interaction in the bone marrow. Proc Natl Acad Sci U S A 104:5091–5096
Yang L, Wang L, Kalfa TA, Cancelas JA, Shang X, Pushkaran S, Mo J, Williams DA, Zheng Y (2007) Cdc42 critically regulates the balance between myelopoiesis and erythropoiesis. Blood 110:3853–3861
Yang L, Zheng Y (2007) Cdc42: a signal coordinator in hematopoietic stem cell maintenance. Cell Cycle 6:1445–1450
Florian MC, Dörr K, Niebel A, Daria D, Schrezenmeier H, Rojewski M, Filippi MD, Hasenberg A, Gunzer M, Scharfetter-Kochanek K, Zheng Y, Geiger H (2012) Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation. Stem Cell 10:520–530
Mizukawa B, O'Brien E, Moreira DC, Wunderlich M, Hochstetler CL, Duan X, Liu W, Orr E, Grimes HL, Mulloy JC, Zheng Y (2017) Cell polarity determinant CDC42 controls division symmetry to block leukemia cell differentiation. Blood 130:1336–1346
Wei J, Wunderlich M, Fox C, Alvarez S, Cigudosa JC, Wilhem JS, Zheng Y, Cancelas JA, Gu Y, Jansen M, Dimartino JF, Mulloy JC (2008) Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. Cancer Cell 13:483–495
Lavau C, Szilvassy SJ, Slany R, Cleary ML (1997) Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J 16:4226–4237
Johnson JJ, Chen W, Hudson W, Yao Q, Taylor M, Rabbitts TH, Kersey JH (2003) Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia. Blood 101:3229–3235
Acknowledgment
The work was supported in part by NIH grants R01 CA204895, R01 CA193350, K12 HD028827, and K12 HD000850, and a St. Baldrick’s Foundation Scholar Award (BM).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Mizukawa, B., O’Brien, E., Mulloy, J.C., Zheng, Y. (2018). Cell Polarity and Division Symmetry Analyses in Transformed Blood Cells. In: Rivero, F. (eds) Rho GTPases. Methods in Molecular Biology, vol 1821. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8612-5_18
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8612-5_18
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8611-8
Online ISBN: 978-1-4939-8612-5
eBook Packages: Springer Protocols